1-197328410-A-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_201253.3(CRB1):​c.71-12A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.414 in 1,590,246 control chromosomes in the GnomAD database, including 145,185 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.35 ( 11869 hom., cov: 32)
Exomes 𝑓: 0.42 ( 133316 hom. )

Consequence

CRB1
NM_201253.3 intron

Scores

2
Splicing: ADA: 0.00006066
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -0.190

Publications

6 publications found
Variant links:
Genes affected
CRB1 (HGNC:2343): (crumbs cell polarity complex component 1) This gene encodes a protein which is similar to the Drosophila crumbs protein and localizes to the inner segment of mammalian photoreceptors. In Drosophila crumbs localizes to the stalk of the fly photoreceptor and may be a component of the molecular scaffold that controls proper development of polarity in the eye. Mutations in this gene are associated with a severe form of retinitis pigmentosa, RP12, and with Leber congenital amaurosis. Alternate splicing results in multiple transcript variants, some protein coding and some non-protein coding.[provided by RefSeq, Apr 2012]
CRB1 Gene-Disease associations (from GenCC):
  • hereditary macular dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • Leber congenital amaurosis 8
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • retinitis pigmentosa 12
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • Leber congenital amaurosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • nanophthalmia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pigmented paravenous retinochoroidal atrophy
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: G2P, Orphanet
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 1-197328410-A-T is Benign according to our data. Variant chr1-197328410-A-T is described in ClinVar as Benign. ClinVar VariationId is 96660.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.761 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CRB1NM_201253.3 linkc.71-12A>T intron_variant Intron 1 of 11 ENST00000367400.8 NP_957705.1 P82279-1A0A7D6VM04

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CRB1ENST00000367400.8 linkc.71-12A>T intron_variant Intron 1 of 11 1 NM_201253.3 ENSP00000356370.3 P82279-1

Frequencies

GnomAD3 genomes
AF:
0.351
AC:
53380
AN:
151902
Hom.:
11864
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0882
Gnomad AMI
AF:
0.195
Gnomad AMR
AF:
0.478
Gnomad ASJ
AF:
0.369
Gnomad EAS
AF:
0.781
Gnomad SAS
AF:
0.430
Gnomad FIN
AF:
0.518
Gnomad MID
AF:
0.332
Gnomad NFE
AF:
0.420
Gnomad OTH
AF:
0.381
GnomAD2 exomes
AF:
0.448
AC:
110331
AN:
246166
AF XY:
0.444
show subpopulations
Gnomad AFR exome
AF:
0.0778
Gnomad AMR exome
AF:
0.576
Gnomad ASJ exome
AF:
0.365
Gnomad EAS exome
AF:
0.791
Gnomad FIN exome
AF:
0.516
Gnomad NFE exome
AF:
0.411
Gnomad OTH exome
AF:
0.416
GnomAD4 exome
AF:
0.420
AC:
604539
AN:
1438226
Hom.:
133316
Cov.:
29
AF XY:
0.420
AC XY:
301211
AN XY:
716906
show subpopulations
African (AFR)
AF:
0.0692
AC:
2281
AN:
32944
American (AMR)
AF:
0.574
AC:
25337
AN:
44156
Ashkenazi Jewish (ASJ)
AF:
0.366
AC:
9494
AN:
25936
East Asian (EAS)
AF:
0.774
AC:
30587
AN:
39504
South Asian (SAS)
AF:
0.414
AC:
35300
AN:
85316
European-Finnish (FIN)
AF:
0.506
AC:
26981
AN:
53342
Middle Eastern (MID)
AF:
0.299
AC:
1689
AN:
5640
European-Non Finnish (NFE)
AF:
0.411
AC:
448532
AN:
1091812
Other (OTH)
AF:
0.409
AC:
24338
AN:
59576
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
15873
31745
47618
63490
79363
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13748
27496
41244
54992
68740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.351
AC:
53385
AN:
152020
Hom.:
11869
Cov.:
32
AF XY:
0.362
AC XY:
26902
AN XY:
74302
show subpopulations
African (AFR)
AF:
0.0879
AC:
3649
AN:
41516
American (AMR)
AF:
0.479
AC:
7314
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.369
AC:
1282
AN:
3472
East Asian (EAS)
AF:
0.781
AC:
4032
AN:
5164
South Asian (SAS)
AF:
0.431
AC:
2074
AN:
4814
European-Finnish (FIN)
AF:
0.518
AC:
5455
AN:
10530
Middle Eastern (MID)
AF:
0.340
AC:
100
AN:
294
European-Non Finnish (NFE)
AF:
0.420
AC:
28503
AN:
67940
Other (OTH)
AF:
0.379
AC:
798
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1524
3049
4573
6098
7622
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
512
1024
1536
2048
2560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.282
Hom.:
1220
Bravo
AF:
0.340
Asia WGS
AF:
0.542
AC:
1887
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Jul 13, 2011
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 25, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Leber congenital amaurosis 8 Benign:2
Jun 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Pigmented paravenous retinochoroidal atrophy Benign:2
Jun 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Retinitis pigmentosa 12;C3151202:Leber congenital amaurosis 8 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Retinitis pigmentosa Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
7.7
DANN
Benign
0.67
PhyloP100
-0.19
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000061
dbscSNV1_RF
Benign
0.0020
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12042179; hg19: chr1-197297540; API